Abstract
This chapter defines the Suspicious of Malignancy category, discusses the reasons why suspicious of malignancy reports occur, and why a definitive diagnosis of malignancy cannot or should not be made in certain circumstances. The category allows for the maintenance of a high positive predictive value of a malignant diagnosis. Many of the reasons for an inability to make a definitive diagnosis of malignancy are similar to those seen in the atypical category and include the specimen quality, which is largely reliant on the skill of the FNAB operator, the experience of the cytopathologist interpreting the smears, and the inherent nature of the lesion. There are overlapping cytological criteria between some breast proliferative and in situ lesions, and between in situ lesions and some malignant tumours, and distinguishing carcinoma and lymphoma also may be difficult on occasion. The chapter details the cytological features of low-grade ductal carcinoma in situ (DCIS), and discusses this controversial area to provide an approach to the diagnosis and differential diagnoses for low-grade DCIS. The management of Suspicious of Malignancy FNAB cytology cases is presented and highlights the need for further investigation by core needle or excision biopsy in all cases. Sample reports are presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ayata G, Abu-Jawdeh GM, Fraser JL, et al. Accuracy and consistency in application of a probabilistic approach to reporting breast FNA. Acta Cytol. 2003;47:973–8.
Chaiwun B, Sukhamwang N, Lekawanvijit S, et al. Atypical and suspicious categories in fine needle aspiration cytology of the breast: histological and mammographical correlation and clinical significance. Singap Med J. 2005;46:706–9.
Nguansangiam S, Jesdapatarakul S, Tangjitgamol S. Accuracy of fine needle aspiration cytology from breast masses in Thailand. Asian Pac J Cancer Prev. 2009;10(4):623–6.
Abdel-Hadi M, Abdel-Hamid GF, Abdel-Razek N, Fawzy RK. Should fine-needle aspiration cytology be the first choice diagnostic modality for assessment of all nonpalpable breast lesions? The experience of a breast cancer screening center in Alexandria, Egypt. Diagn Cytopathol. 2010;38(12):880–9.
Goyal P, Sehgal S, Ghosh S, et al. Histopathological correlation of atypical (C3) and suspicious (C4) categories in FNA cytology of the breast. Int J Breast Cancer. 2013;2013:48.
Weigner J, Zardawi I, Braye S, et al. The microscopic complexities of C3 in breast cytology. Acta Cytol. 2014;58:335–46.
Aker F, Gumrukcu G, Onomay BC, et al. Accuracy of fine-needle aspiration cytology in the diagnosis of breast cancer a single-center retrospective study from Turkey with cytohistological correlation in 733 cases. Diagn Cytopathol. 2015;43(12):978–86.
Daramola AO, Odubanjo MO, Obiajulu FJ, Ikeri NZ, Banjo AA. Correlation between fine-needle aspiration cytology and histology for palpable breast masses in a Nigerian tertiary health institution. Int J Breast Cancer. 2015;2015:742573.
Arul P, Masilamani S, Akshatha C. FNA cytology of atypical (C3) and suspicious (4) categories in the breast and its histopathologic correlation. J Cytol. 2016;33:76–9.
Miskovic J, Zoric A, Radic Miskovic H, Soljic V. Diagnostic value of fine needle aspiration cytology for breast tumors. Acta Clin Croat. 2016;55(4):625–8.
Dong J, Ly A, Arpin R, et al. Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital. Breast Cancer Res Treat. 2016;158:297–305.
Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: a systematic review and meta-analysis. Breast. 2017;31:157–66.
Yu S-N, Li J, Wong S-I, et al. Atypical aspirates of the breast: a dilemma in current cytology practice. J Clin Pathol. 2017;70(12):1024–32.
Hoda R, Brachtel E. IAC Yokohama system for reporting breast FNAB cytology: a review of predictive values and risks of malignancy. Acta Cytol. 2019;63:292–301.
Montezuma D, Malheiros D, Schmitt F. Breast FNAB cytology using the newly proposed IAC Yokohama system for reporting breast cytopathology: the experience of a single institution. Acta Cytol. 2019;63:274–9.
Wong S, Rickard M, Earls P, Arnold L, Bako B, Field AS. The IAC Yokohama System for Reporting Breast FNAB Cytology: a single institutional retrospective study of the application of the System and the impact of ROSE. Acta Cytol. 2019;63:280–91.
Ljung BM, Drejet A, Chiampi N, et al. Diagnostic accuracy of FNAB is determined by physician training in sampling technique. Cancer Cytopathol. 2001;93:263–8.
Lee KR, Foster RS, Papillo JL. Fine needle aspiration of the breast. Importance of the aspirator. Acta Cytol. 1987;31:281–4.
Bofin AM, Lydersen S, Hagmar BM. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Diagn Cytopathol. 2004;31:207–15.
Simsir A, Waisman J, Cangiarella J. Fibroadenomas with atypia: causes of under and overdiagnois by aspiration biopsy. Diagn Cytopathol. 2001;25:278–84.
Field AS, Mak A. A prospective study of the diagnostic accuracy of cytological criteria in the FNAB diagnosis of breast papillomas. Diagn Cytopathol. 2007;35:465–75.
Orell S. Radial scar/complex sclerosing lesion—a problem in the diagnostic work-up of screen detected breast lesions. Cytopathology. 1999;10:250–8.
Silverman JF, Masood S, Ducatman BS, et al. Can FNA biopsy separate atypical hyperplasia, carcinoma in-situ, and invasive carcinoma of the breast? Cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol. 1993;24:630–5.
Deb RA, Matthews P, Elston CW, et al. An audit of ‘equivocal’ (C3) and suspicious (C4) categories in FNA cytology of breast. Cytopathology. 2001;1:219–26.
Ciatto S, Cariaggi P, Bulgaresi P, Confortini M, Bonardi R. Fine needle aspiration cytology of the breast: review of 9533 consecutive cases. Breast. 1993;2:87–90.
Park IA, Ham EK. Fine needle aspiration cytology of palpable breast lesions. Histologic subtype in false negative cases. Acta Cytol. 1997;41:1131–8.
Bonzanini M, Gilioli E, Brancato B, et al. The cytopathology of ductal carcinoma in situ of the breast. A detailed analysis of fine needle aspiration cytology of 58 cases compared with 101 invasive ductal carcinomas. Cyopathology. 2001;12(2):107–19.
Cangiarella J, Waisman J, Simsir A. Cytologic findings with histologic correlation in 43 cases of mammary intraductal adenocarcinoma diagnosed by aspiration biopsy. Acta Cytol. 2003;47:965–72.
Lilleng R, Hagmar B. The comedo subtype of intraductal carcinoma. Cytologic characteristics. Acta Cytol. 1992;36:345–52.
Sauer T, Young K, Thoresen Sø. Fine needle aspiration cytology in the work-up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinoma. Cytopathology. 2002;13(2):101–10.
Abdel-Fatah TMA, Powe DG, Hodi Z, et al. Morphological and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of a low-grade breast neoplasia family. Am J Surg Pathol. 2008;32:513–23.
Sauer T, Myrvold K, Lomo J, Anderssen KY, Skaane P. Fine-needle aspiration cytology in nonpalpable mammographic abnormalities in breast cancer screening: results from the breast cancer screening programme in Oslo 1996-2001. Breast. 2003;12(5):314–9.
Lakhani SREI, Schnitt SJ, Tan PH, van de Vivjer M, editors. In: WHO classification of tumours of the breast. 4th ed. Lyon: International Agency for Research of Cancer; 2012.
Silverstein MJ, Poller DN, Waisman J. Prognostic classification of breast ductal carcinoma-in situ. Lancet. 1995;345:1154–7.
Sauer T, Lõmo J, Garred ù, Nëss O. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading. Cancer Cytopathol. 2005;105(1):21–7.
Beca F, Schmitt FS. Ancillary tests in breast FNAB cytology: a practical guide to current use. Acta Cytol. 2019;63:302–13.
Field AS. Chapter 5 Breast. In: Field AS, Zarka MA, editors, Practical Cytopathology: a Diagnostic Approach to FNA Biopsy. Philadelphia: Elsevier; 2017.
Gibbons CE, Quinn CM, Gibbons D. Fine needle aspiration biopsy management of the axilla in primary breast carcinoma. Acta Cytol. 2019;63(4):314–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Field, A.S. et al. (2020). Suspicious of Malignancy. In: Field, A.S., Raymond, W.A., Schmitt, F. (eds) The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-26883-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-26883-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26882-4
Online ISBN: 978-3-030-26883-1
eBook Packages: MedicineMedicine (R0)